Highlights
1 patent
About
Slow-release Transmucosal Drug Delivery Systems
NovaLaka develops technology in the field of slow-release drug-delivery systems, specializing in transmucosal solutions for women's healthcare applications. The company has developed a polymeric composition that serves as a drug-delivery system specifically designed for mucosal tissue such as the eyes. The polymeric matrix gradually releases the desired medication directly to the area requiring treatment. NovaLaka's polymeric film can serve as a vehicle for any active ingredient, delivering it directly through the tissue effectively and in a controlled manner. In 2017, NovaLaka won the first prize at the Global Pitch of China.
Identity
| Name | NovaLaka |
|---|---|
| Slug | novalaka |
| Type / kind | startup |
| Crunchbase ID | novalaka |
| Source _id | agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgI2E_JgJDA |
Status
| Status | inactive |
|---|---|
| Status reason | Non Active, Dec 2019 ceased to operate |
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ region/district | Jerusalem District |
| HQ city | Jerusalem |
| HQ address | Beit HaKerem Street 26, Jerusalem, Israel |
Web & social
| https://www.linkedin.com/company/10268100 | |
| https://www.facebook.com/NovaLaka1 | |
| https://www.instagram.com/novalaka |
Classifications
Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
Biologicals
Target customers
ConsumersDemographics & FamilyWomenHealthcare & Life SciencesLife SciencesPharmaceuticals
Business models
B2B
Tags
polymerssustained-releaseburnstopical-treatmentdrug-deliverypharmaceuticalspharma-companies
Funding
| Total raised | $57K |
|---|---|
| Current stage | Seed |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}